Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$45.13 - $64.99 $1.26 Million - $1.81 Million
-27,900 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$29.77 - $84.85 $77,134 - $219,846
-2,591 Reduced 8.5%
27,900 $1.77 Million
Q4 2020

Feb 02, 2021

SELL
$25.66 - $34.55 $15,396 - $20,730
-600 Reduced 1.93%
30,491 $1.02 Million
Q3 2020

Nov 05, 2020

BUY
$22.51 - $30.11 $18,008 - $24,088
800 Added 2.64%
31,091 $850,000
Q2 2020

Aug 12, 2020

BUY
$12.65 - $29.57 $383,181 - $895,704
30,291 New
30,291 $819,000

Others Institutions Holding MORF

About Morphic Holding, Inc.


  • Ticker MORF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,477,100
  • Market Cap $2.19B
  • Description
  • Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...
More about MORF
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.